Maple Rose Enterprises, Inc, dba Pencol PharmacyFebruary 26, 2019

FDA 483 - Maple Rose Enterprises, Inc, dba Pencol Pharmacy - February 26, 2019

FDA 483 for Maple Rose Enterprises, Inc, dba Pencol Pharmacy on February 26, 2019. Product: N/A. Access full analysis and detailed observations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA 483 for Maple Rose Enterprises, Inc, dba Pencol Pharmacy on February 26, 2019. Product: N/A. Access full analysis and detailed observations.

Violation Codes

FD&C Act 501(a)(2)(B)

21 CFR 211.68(a)

21 CFR 211.165(d)

21 CFR 211

21 CFR 211.67(a)

21 CFR 211.42(c)

21 CFR 211.46(b)

21 CFR 211.68(b)

21 CFR 210

21 CFR 211.180(e)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Maple Rose Enterprises, Inc, dba Pencol Pharmacy

Inspection Date

February 26, 2019

Product Type

Office

Denver District Office

People

ID: 8e9e966c-41f1-4e4a-8a0c-eb07fe1e191e

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox